News | June 29, 2025
Torrent Pharma to acquire KKR’s stake in JB Pharma for Rs. 25,689 Cr
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
India Business grew by 11.9% YoY to Rs. 1196.2 crore
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
40,000 visitors and representatives of more than 80 countries set to visit the show
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
The stability is led by healthy demand in the domestic and emerging markets
The company reports revenue growth of 26% and PAT growth of 21% YoY
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
Subscribe To Our Newsletter & Stay Updated
